Therapeutic effects of direct renin inhibitor aliskiren on ambulatory blood pressure profile in essential hypertensives
Phase 4
Recruiting
- Conditions
- Essential hypertension
- Registration Number
- JPRN-UMIN000003936
- Lead Sponsor
- Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1. Office systolic blood pressure >= 180 mmHg, or office diastolic blood pressure >= 110 mmHg. 2. Heart disease, cerebrovascular disease, or ckronic kidney disease with urinary protein excretion >= 300 mg/g-cr or estimated GFR < 60 ml/min/1.73 m2. 3. Cyclosporin treatment. 4. History of hypersensitivity of aliskiren. 5. Pregnant women or women suspect of being pregnant. 6. Arrhythmia. 7. Secondary hypertension. 8. Patients ineligible for the study determined by doctors
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method